Sri Lanka has announced to purchase 1.35 crore doses in addition to the 5 lakh Oxford-AstraZeneca vaccine supplements offered by India. In this regard, a government spokesman said on Tuesday that it is possible that the country will not use China’s vaccine in the second phase of vaccination.
Plantation Minister Ramesh Pathirana said that due to the vaccine in China and Russia not yet ready, it is possible that in the second phase of vaccination, Sri Lanka will use only the dose of AstraZeneca vaccines.
Pathirana said the Chinese vaccine has not submitted documents related to the Phase III trial. For the first stage vaccination, the government has ordered the purchase of one crore vaccine supplements from the Serum Institute of India at a price of $ 5.25 million.
At the same time, under the Kovacs program, the purchase of 3.5 million doses has been announced directly from the AstraZeneca Institute in Britain. India introduced 5 lakh doses of the same vaccine to Sri Lanka at the end of January, following which the vaccination campaign in Sri Lanka began. Sri Lankan President Gotabaya Rajapaksa expressed gratitude for India’s generosity.